HEMODYNAMIC, RENAL, AND HORMONAL RESPONSES TO BRAIN NATRIURETIC PEPTIDE INFUSION IN PATIENTS WITH CONGESTIVE-HEART-FAILURE

被引:391
|
作者
YOSHIMURA, M
YASUE, H
MORITA, E
SAKAINO, N
JOUGASAKI, M
KUROSE, M
MUKOYAMA, M
SAITO, Y
NAKAO, K
IMURA, H
机构
[1] KUMAMOTO UNIV,SCH MED,DIV CARDIOL,1-1-1 HONJO,KUMAMOTO 860,JAPAN
[2] NATL CARDIOVASC CTR,RES INST,SUITA,OSAKA 565,JAPAN
[3] KYOTO UNIV,SCH MED,DEPT MED,DIV 2,KYOTO 606,JAPAN
关键词
ATRIAL NATRIURETIC PEPTIDE; BRAIN NATRIURETIC PEPTIDE; CONGESTIVE HEART FAILURE; NATRIURESIS;
D O I
10.1161/01.CIR.84.4.1581
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. This study was designed to examine the hemodynamic, renal, and hormonal effects of brain natriuretic peptide (BNP) infusion in patients with congestive heart failure (CHF) and in control subjects. Methods and Results. We infused synthetic human BNP at a rate of 0.1-mu-g/kg/min. BNP infusion decreased pulmonary capillary wedge pressure (control, from 5 +/- 1 to 2 +/- 1 mm Hg, p < 0.01; CHF, from 21 +/- 3 to 14 +/- 4 mm Hg, p < 0.05) and systemic vascular resistance (control, from 1,264 +/- 75 to 934 +/- 52 dyne.sec.cm-5; CHF, from 2,485 +/- 379 to 1,771 +/- 195 dyne.sec.cm-5; p < 0.01, respectively) and increased stroke volume index (control, from 49.9 +/- 2.7 to 51.5 +/- 2.3 ml/m2, p = NS; CHF, from 25.6 +/- 3.8 to 32.0 +/- 3.9 ml/m2, p < 0.01). BNP infusion significantly increased urine volume (control, from 2.3 +/- 0.7 to 7.5 +/- 1.9 ml/min; CHF, from 0.8 +/- 0.2 to 5.3 +/- 1.0 ml/min; p < 0.01, respectively), excretion of sodium (control, from 79.2 +/- 21.6 to 332.8 +/- 70.9-mu-Eq/min; CHF, from 77.4 +/- 20.8 to 753.5 +/- 108.0-mu-Eq/min; p < 0.01, respectively), and excretion of chloride (control, from 72.5 +/- 18.4 to 256.0 +/- 43.3-mu-Eq/min; CHF, from 74.0 +/- 19.6 to 708.8 +/- 103.3-mu-Eq/min; p < 0.01, respectively). Urinary excretion of sodium and of chloride in response to BNP infusion was higher in patients with CHF than in control subjects (p < 0.01, respectively). BNP infusion increased the levels of plasma atrial natriuretic peptide (control, from 65 +/- 11 to 84 +/- 14 pg/ml; CHF, from 262 +/- 65 to 301 +/- 62 pg/ml; p < 0.05, respectively) and decreased plasma aldosterone concentrations in both groups (control, from 43.3 +/- 12.1 to 27.3 +/- 7.1 pg/ml; CHF, from 91.1 +/- 34.3 to 66.3 +/- 27.2 pg/ml; p < 0.05, respectively). Conclusions. We conclude that BNP infusion improves left ventricular function in patients with CHF by vasodilation and prominent natriuretic action.
引用
收藏
页码:1581 / 1588
页数:8
相关论文
共 50 条
  • [31] COMPARATIVE HEMODYNAMIC AND HORMONAL RESPONSE OF ENOXIMONE AND DOBUTAMINE IN SEVERE CONGESTIVE-HEART-FAILURE
    URETSKY, BF
    GENERALOVICH, T
    VERBALIS, JG
    VALDES, AM
    REDDY, PS
    AMERICAN JOURNAL OF CARDIOLOGY, 1986, 58 (01): : 110 - 116
  • [32] ATRIAL-NATRIURETIC-PEPTIDE CONCENTRATION IN DOGS WITH CONGESTIVE-HEART-FAILURE, CHRONIC-RENAL-FAILURE, AND HYPERADRENOCORTICISM
    VOLLMAR, AM
    REUSCH, C
    KRAFT, W
    SCHULZ, R
    AMERICAN JOURNAL OF VETERINARY RESEARCH, 1991, 52 (11) : 1831 - 1834
  • [33] ACUTE HEMODYNAMIC, HORMONAL AND ELECTROLYTE EFFECTS OF RAMIPRIL IN SEVERE CONGESTIVE-HEART-FAILURE
    CROZIER, IG
    IKRAM, H
    NICHOLLS, MG
    JANS, S
    AMERICAN JOURNAL OF CARDIOLOGY, 1987, 59 (10): : D155 - D163
  • [34] RENAL AND SYSTEMIC HEMODYNAMIC-EFFECTS OF IBOPAMINE IN PATIENTS WITH MILD CONGESTIVE-HEART-FAILURE
    LIEVERSE, AG
    VANVELDHUISEN, DJ
    SMIT, AJ
    ZIJLSTRA, JG
    MEIJER, S
    REITSMA, WD
    LIE, KI
    GIRBES, ARJ
    KIDNEY INTERNATIONAL, 1993, 44 (05) : 1196 - 1196
  • [35] HEMODYNAMIC AND NEUROHUMORAL RESPONSES TO INTRAVENOUS NICORANDIL IN CONGESTIVE-HEART-FAILURE IN HUMANS
    GILES, TD
    PINA, IL
    QUIROZ, AC
    ROFFIDAL, L
    ZALESKI, R
    PORTER, RS
    KARALIS, DG
    MOHRLAND, JS
    WOLF, DL
    HEARRON, AE
    SANDER, GE
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1992, 20 (04) : 572 - 578
  • [36] CENTRAL AND PERIPHERAL HEMODYNAMIC-RESPONSES TO FELODIPINE IN CONGESTIVE-HEART-FAILURE
    CAPEWELL, S
    WATHEN, CG
    MUIR, AL
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1991, 41 (02) : 95 - 98
  • [37] Hemodynamic and renal excretory effects of human brain natriuretic peptide infusion in patients with congestive heart failure - A double-blind, placebo-controlled, randomized crossover trial
    Marcus, LS
    Hart, D
    Packer, M
    Yushak, M
    Medina, N
    Danziger, RS
    Heitjan, DF
    Katz, SD
    CIRCULATION, 1996, 94 (12) : 3184 - 3189
  • [38] RENAL-CARDIOVASCULAR-ENDOCRINE ACTIONS OF ATRIAL-NATRIURETIC-PEPTIDE IN HUMANS WITH CONGESTIVE-HEART-FAILURE
    BURNETT, JC
    EDWARDS, BS
    SCHWAB, TR
    ZIMMERMAN, RS
    GERSH, BJ
    SMITH, RD
    HEUBLEIN, DM
    CLINICAL RESEARCH, 1986, 34 (04): : A970 - A970
  • [39] RENAL EFFECTS OF HIGH-DOSE NATRIURETIC PEPTIDE RECEPTOR BLOCKADE IN RATS WITH CONGESTIVE-HEART-FAILURE
    ZHANG, PL
    MACKENZIE, HS
    TOTSUNE, K
    TROY, JL
    BRENNER, BM
    CIRCULATION RESEARCH, 1995, 77 (06) : 1240 - 1245
  • [40] Hemodynamic, renal, and hormonal effects of ghrelin infusion in patients with chronic heart failure
    Nagaya, N
    Miyatake, K
    Uematsu, M
    Oya, H
    Shimizu, W
    Hosoda, H
    Kojima, M
    Nakanishi, N
    Mori, H
    Kangawa, K
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (12): : 5854 - 5859